DiscoveRx
DiscoveRx Acquires BioSeek
NEW YORK (GenomeWeb News) – DiscoveRx today said that it has acquired BioSeek, maker of the BioMAP platform of cell-based disease models for drug screening. Financial terms of the deal were not disclosed.
Compugen, DiscoveRx Collaborate to Commercialize Peptides for GPCR Targets
NEW YORK (GenomeWeb News) – Compugen and DiscoveRx today announced a collaboration to commercialize specially designed peptides matched with specific G protein-coupled receptor targets.
By Adam Bonislawski
Two papers published in the current edition of Nature Biotechnology add significantly to the publicly available data on the specificity of kinase inhibitors.
DiscoveRx Acquires KinomeScan Division from Ambit Biosciences
Starting in the first quarter of 2011, DiscoveRx plans to add its own panel of cell-based assays to the KinomeScan service as an offering.
DiscoveRx Partners with Jubilant Biosys
The co-marketing agreement will give Jubilant’s drug developer customers cell-based screening services.
Oct 8, 2009